{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:23:20Z","timestamp":1772861000310,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007614","name":"Al Jouf University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bioorg.2019.102964","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T11:54:27Z","timestamp":1556625267000},"page":"102964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold"],"prefix":"10.1016","volume":"88","author":[{"given":"Rania B.","family":"Bakr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira A.","family":"Ghoneim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A.","family":"Azouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.102964_b0005","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.M703169200","article-title":"Enzymes and receptors of prostaglandin pathways with arachidonic acid-vs. eicosapentaenoic acid-derived substrates and products","volume":"282","author":"Wada","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","article-title":"Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology","volume":"14","author":"Harizi","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bioorg.2019.102964_b0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtherbio.2005.11.008","article-title":"Cyclooxygenase: past present and future. A tribute to John R. Vane (1927\u20132004)","volume":"31","author":"Botting","year":"2006","journal-title":"J. Therm. Biol"},{"key":"10.1016\/j.bioorg.2019.102964_b0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.ki.5002058","article-title":"Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes","volume":"71","author":"Cuzzocrea","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.bioorg.2019.102964_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3121\/cmr.2007.698","article-title":"An evidence-based update on nonsteroidal anti-inflammatory drugs","volume":"5","author":"Ong","year":"2007","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.bioorg.2019.102964_b0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1365-2516.2007.01453.x","article-title":"S.M.H.S. Group Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non-steroidal anti-inflammatory drugs","volume":"13","author":"Eyster","year":"2007","journal-title":"Haemophilia"},{"key":"10.1016\/j.bioorg.2019.102964_b0035","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2174\/1568026616666160927153435","article-title":"Nitric oxide-NASIDS donor prodrugs as hybrid safe anti-inflammatory agents","volume":"17","author":"Ra Abdellatif","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/ACO.0b013e3283007e8d","article-title":"Pharmacology of cyclooxygenase-2 inhibitors and preemptive analgesia in acute pain management","volume":"21","author":"Kaye","year":"2008","journal-title":"Current Opin. Anesthesiol."},{"key":"10.1016\/j.bioorg.2019.102964_b0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00228-007-0400-7","article-title":"Clinical use and pharmacological properties of selective COX-2 inhibitors","volume":"64","author":"Shi","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.102964_b0050","first-page":"81","article-title":"Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond","volume":"11","author":"Rao","year":"2008","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.bioorg.2019.102964_b0055","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2174\/138161206776055949","article-title":"Coxibs and cardiovascular side-effects: from light to shadow","volume":"12","author":"Dogne","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2019.102964_b0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejmech.2011.11.006","article-title":"Stereoselective synthesis and QSAR study of cytotoxic 2-(4-oxo-thiazolidin-2-ylidene)-2-cyano-N-arylacetamides","volume":"47","author":"George","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2012.10.044","article-title":"2H-chromene derivatives bearing thiazolidine-2, 4-dione, rhodanine or hydantoin moieties as potential anticancer agents","volume":"59","author":"Azizmohammadi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0070","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ejmech.2008.10.006","article-title":"Synthesis antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones","volume":"44","author":"Gouveia","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0075","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1016\/j.ejmech.2010.04.029","article-title":"Conventional and microwave assisted synthesis of Some new N-[(4-oxo-2-substituted aryl\u2212 1, 3-thiazolidine)-acetamidyl]-5-nitroindazoles and its antimicrobial activity","volume":"45","author":"Upadhyay","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0080","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/cbdd.12102","article-title":"Discovery of thiazolidine-2, 4-dione\/biphenylcarbonitrile hybrid as dual PPAR \u03b1\/\u03b3 modulator with antidiabetic effect: in vitro silico and in vivo approaches","volume":"81","author":"Hidalgo-Figueroa","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2019.102964_b0085","unstructured":"S. Pattan, C. Suresh, V. Pujar, V. Reddy, V. Rasal, B. Koti, Synthesis and antidiabetic activity of 2-amino [5'(4-sulphonylbenzylidine)-2, 4-thiazolidinedione]-7-chloro-6-fluorobenzothiazole, 44B (2005) 2404-2408."},{"key":"10.1016\/j.bioorg.2019.102964_b0090","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ardp.200390007","article-title":"Design and synthesis of some substituted 1H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents","volume":"336","author":"Bekhit","year":"2003","journal-title":"Archiv der Pharmazie: An Int. J. Pharmaceut. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/HC.2005.11.2.121","article-title":"Synthesis and anti-inflammatory activity of new thiazolidine-2, 4-diones, 4-thioxothiazolidinones and 2-thioxoimidazolidinones","volume":"11","author":"Santos","year":"2005","journal-title":"Heterocycl. Commun."},{"key":"10.1016\/j.bioorg.2019.102964_b0100","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1016\/j.bmcl.2007.07.084","article-title":"Synthesis of 2, 3-diaryl-1, 3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors","volume":"17","author":"Zarghi","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102964_b0105","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmech.2014.12.036","article-title":"Structural exploration, synthesis and pharmacological evaluation of novel 5-benzylidenethiazolidine-2, 4-dione derivatives as iNOS inhibitors against inflammatory diseases","volume":"92","author":"Ma","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0110","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1016\/j.bmc.2005.06.063","article-title":"Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives","volume":"13","author":"Sondhi","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0115","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.bmcl.2012.03.092","article-title":"A novel pyrimidine derivatives with aryl urea, thiourea and sulfonamide moieties: synthesis, anti-inflammatory and antimicrobial evaluation","volume":"22","author":"Keche","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.102964_b0120","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.3390\/molecules15031882","article-title":"Synthesis of certain pyrimidine derivatives as antimicrobial agents and anti-inflammatory agents","volume":"15","author":"Mohamed","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2019.102964_b0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.biopha.2011.04.023","article-title":"Synthesis of cyanopyridine and pyrimidine analogues as new anti-inflammatory and antimicrobial agents","volume":"65","author":"Kumar","year":"2011","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2019.102964_b0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.bioorg.2018.01.028","article-title":"Novel pyrimidine-pyridine hybrids: synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability","volume":"77","author":"Abdelgawad","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/14756366.2016.1186018","article-title":"Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo [3, 4-d] pyrimidine derivatives","volume":"31","author":"Bakr","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0140","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.4155\/fmc-2017-0115","article-title":"Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect","volume":"9","author":"Abdelgawad","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2019.102964_b0145","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1080\/16583655.2018.1510163","article-title":"Synthesis and studies molecular docking of some new thioxobenzo [g] pteridine derivatives and 1, 4-dihydroquinoxaline derivatives with glycosidic moiety","volume":"12","author":"Ghoneim","year":"2018","journal-title":"J. Taibah Univ. Sci."},{"key":"10.1016\/j.bioorg.2019.102964_b0150","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1007\/s00044-015-1327-7","article-title":"Synthesis, cyclooxygenase inhibition, and anti-inflammatory evaluation of novel diarylheterocycles with a central pyrazole, pyrazoline, or pyridine ring","volume":"24","author":"Abdellatif","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2019.102964_b0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3998\/ark.5550190.0008.g16","article-title":"Synthesis and antimicrobial screening of 5-arylidene-2-imino-4-thiazolidinones","volume":"16","author":"Chavan","year":"2007","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2019.102964_b0160","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.3390\/molecules17066362","article-title":"4-Thiazolidinones in heterocyclic synthesis: synthesis of novel enaminones, azolopyrimidines and 2-Arylimino-5-arylidene-4-thiazolidinones","volume":"17","author":"Behbehani","year":"2012","journal-title":"Molecules"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819302512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819302512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:50:10Z","timestamp":1758613810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819302512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":32,"alternative-id":["S0045206819302512"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.102964","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.102964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102964"}}